Effects of subinhibitory concentrations of ciprofloxacin on staphylococcus saprophyticus adherence and virulence in urinary tract infections

Journal of Endourology

Volumn 26, Issue 1, 2012, Pages 32-37

  Erdeljan, Petar ^a,b   MacDonald, Kyle W ^a,b   Goneau, Lee W ^a,b   Bevan, Tyler ^c   Carriveau, Rupp ^c   Razvi, Hassan ^a,b   Denstedt, John D ^a,b   Cadieux, Peter A ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF WINDSOR   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; INTERLEUKIN 6; INTERLEUKIN 8;

ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BLADDER; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAPHYLOCOCCUS SAPROPHYTICUS; UPREGULATION; URETER STENT; URINARY TRACT INFECTION;

BACTERIAL ADHESION; CELL LINE; CIPROFLOXACIN; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INFLAMMATION MEDIATORS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS SAPROPHYTICUS; URINARY BLADDER; URINARY TRACT INFECTIONS; VIRULENCE;

EID: 84855425147     PISSN: 08927790     EISSN: 1557900X     Source Type: Journal    
DOI: 10.1089/end.2011.0183     Document Type: Article

References (27)

1. Laupland KB, Ross T, Pitout JD, et al. Community-onset urinary tract infections: A population-based assessment. Infection 2007;35:150-153. (Pubitemid 46932329)
2. Griebling TL. Urologic diseases in America project: Trends in resource use for urinary tract infections in men. J Urol 2005;173:1288-1294. (Pubitemid 40380556)
3. Griebling TL. Urologic diseases in America project: Trends in resource use for urinary tract infections in women. J Urol 2005;173:1281-1287. (Pubitemid 40380555)
4. Foxman B. Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs. Am J Med 2002; 113(suppl 1A):5S-13S. (Pubitemid 34756640)
5. Arredondo-Garcia JL, Figueroa-Damián R, Rosas A, et al. Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: A randomized, multicentre, openlabel, prospective study. J Antimicrob Chemother 2004; 54:840-843. (Pubitemid 39386743)
6. Gupta K, Hooton TM, Roberts PL, Stamm WE. Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women. Arch Intern Med 2007;167:2207-2212. (Pubitemid 350106740)
7. Nicolle LE, Madsen KS, Debeeck GO, et al. Three days of pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women. Scand J Infect Dis 2002;34:487-492.
8. Naber KG, Cho YH, Matsumoto T, Schaeffer AJ. Immunoactive prophylaxis of recurrent urinary tract infections: A meta-analysis. Int J Antimicrob Agents 2009;33:111-119.
9. Wagenlehner FM, Weidner W, Naber KG. An update on uncomplicated urinary tract infections in women. Curr Opin Urol 2009;19:368-374.
10. Hooton TM. Recurrent urinary tract infection in women. Int J Antimicrob Agents 2001;17:259-268. (Pubitemid 32288741)
11. Epp A, Larochelle A, Lovatsis D, et al. Recurrent urinary tract infection. J Obstet Gynaecol Can 2010;32:1082-1101.
12. Conway PH, Cnaan A, Zaoutis T, et al. Recurrent urinary tract infections in children: Risk factors and association with prophylactic antimicrobials. JAMA 2007;298:179-186. (Pubitemid 47057764)
13. von Eiff C, Peters G, Heilmann C. Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis 2002;2:677-685. (Pubitemid 35265063)
14. Schneider PF, Riley TV. Staphylococcus saprophyticus urinary tract infections: Epidemiological data from Western Australia. Eur J Epidemiol 1996;12:51-54. (Pubitemid 26228695)
15. Hovelius B, Mardh PA. Staphylococcus saprophyticus as a common cause of urinary tract infections. Rev Infect Dis 1984;6:328-337.
16. Jellheden B, Norrby RS, Sandberg T. Symptomatic urinary tract infection in women in primary health care. Bacteriological, clinical and diagnostic aspects in relation to host response to infection. Scand J Prim Health Care 1996;14:122-128.
17. Fowler JE. Staphylococcus saprophyticus as the cause of infected urinary calculus. Ann Intern Med 1985;102: 342-343.
18. Mesak LR, Miao V, Davies J. Effects of subinhibitory concentrations of antibiotics on SOS and DNA repair gene expression in Staphylococcus aureus. Antimicrob Agents Chemother 2008;52:3394-3397.
19. Goh EB, Yim G, Tsui W, et al. Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics. Proc Natl Acad Sci U S A 2002;99: 17025-17030. (Pubitemid 36034092)
20. Mesak LR, Davies J. Phenotypic changes in ciprofloxacinresistant Staphylococcus aureus. Res Microbiol 2009;160: 785-791.
21. Shaw C, Stitt JM, Cowan ST. Staphylococci and their classification. J Gen Microbiol 1951;5(suppl 5):1010-1023.
22. Kline KA, Ingersoll MA, Nielsen HV, et al. Characterization of a novel murine model of Staphylococcus saprophyticus urinary tract infection reveals roles for Ssp and SdrI in virulence. Infect Immun 2010;78:1943-1951.
23. Davies J, Spiegelman GB, Yim G. The world of subinhibitory antibiotic concentrations. Curr Opin Microbiol 2006;9:445-453. (Pubitemid 44397635)
24. Blickwede M, Goethe R, Wolz C, et al. Molecular basis of florfenicol-induced increase in adherence of Staphylococcus aureus strain Newman. J Antimicrob Chemother 2005;56: 315-323. (Pubitemid 41158519)
25. Cadieux PA, Chew BH, Nott L, et al. Use of triclosan-eluting ureteral stents in patients with long-term stents. J Endourol 2009;23:1187-1194.
26. Ingersoll MA, Kline KA, Nielsen HV, et al. G-CSF induction early in uropathogenic Escherichia coli infection of the urinary tract modulates host immunity. Cell Microbiol 2008;10: 2568-2578.
27. Wood MW, Breitschwerdt EB, Gookin JL. Autocrine effects of interleukin-6 mediate acute-phase proinflammatory and tissue-reparative transcriptional responses of canine bladder mucosa. Infect Immun 2011;79:708-715.